InfuSystem (NYSE:INFU) Stock Price Up 0.3% – What’s Next?

InfuSystem Holdings, Inc. (NYSE:INFU)’s share price shot up 0.3% during trading on Monday. The stock traded as high as $13.82 and last traded at $13.60. Approximately 116,348 shares were traded during trading, a decline of 28% from the average session volume of 160,509 shares. The stock had previously closed at $13.56.

Analyst Upgrades and Downgrades

Separately, B. Riley Financial restated a “buy” rating and set a $20.00 target price (up from $12.00) on shares of InfuSystem in a report on Wednesday, August 5th. Two analysts have rated the stock with a Buy rating. According to data from MarketBeat, InfuSystem presently has a consensus rating of “Buy” and a consensus price target of $17.50.

InfuSystem Trading Up 0.8%

The firm has a market cap of $274.48 million, a PE ratio of 226.70 and a beta of 1.49. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The stock’s fifty day simple moving average is $12.52 and its two-hundred day simple moving average is $10.55.

Institutional Trading of InfuSystem

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in InfuSystem in the second quarter worth $15,299,000. Meros Investment Management LP purchased a new stake in shares of InfuSystem in the second quarter worth $4,525,213. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of InfuSystem in the second quarter worth $803,000. Bank of New York Mellon Corp bought a new position in shares of InfuSystem during the second quarter valued at $995,000. Finally, Heartland Advisors Inc. bought a new position in shares of InfuSystem during the second quarter valued at $6,755,000. Hedge funds and other institutional investors own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings, Inc is a provider of ambulatory infusion pump services and related healthcare solutions. The company supplies electronic infusion pumps and supports their use outside traditional hospital settings, helping patients receive prescribed therapies at home, in physician offices, and in other outpatient environments.

Its services include pump and equipment management, biomedical maintenance and repair, clinical support, patient education, supply and logistics services, and insurance and revenue-cycle support.